Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025)

InMed Pharmaceuticals' Change in Inventory history spans 4 years, with the latest figure at $127091.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 208.89% year-over-year to $127091.0; the TTM value through Dec 2025 reached -$85458.0, down 121.32%, while the annual FY2025 figure was -$283151.0, 327.59% down from the prior year.
  • Change in Inventory reached $127091.0 in Q4 2025 per INM's latest filing, up from -$70366.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.1 million in Q2 2022 to a low of -$390329.0 in Q3 2023.
  • Average Change in Inventory over 4 years is $40239.1, with a median of -$47308.5 recorded in 2024.
  • Peak YoY movement for Change in Inventory: skyrocketed 399.09% in 2024, then plummeted 190.16% in 2025.
  • A 4-year view of Change in Inventory shows it stood at -$165017.0 in 2022, then plummeted by 31.98% to -$217784.0 in 2023, then surged by 46.41% to -$116717.0 in 2024, then skyrocketed by 208.89% to $127091.0 in 2025.
  • Per Business Quant, the three most recent readings for INM's Change in Inventory are $127091.0 (Q4 2025), -$70366.0 (Q3 2025), and $147203.0 (Q2 2025).